Kemin Receives ANVISA Approval for Sale of ZeaONE

635899182152549903eyehealth.jpg

01 Feb 2016 --- ANVISA, Brazil’s national Health Surveillance Agency, has approved for sale its product, ZeaONE Zeaxanthin - a naturally sourced dietary free-form of zeaxanthin from marigolds. 

ZeaONE is a dietary free-form zeaxanthin ingredient naturally sourced from marigolds produced by Kemin. Zeaxanthin, like lutein, is proven to act as a protective antioxidant and filter of blue light in the eye and skin. Scientific evidence shows that supplementing diets with lutein and zeaxanthin daily:
• helps keep skin healthy,
• improves visual performance, and
• reduces the risk of certain eye conditions.

Latest findings from the US National Eye Institute’s second age-related eye disease study (AREDS2) report that 2mg of zeaxanthin, along with 10mg of FloraGLO Lutein, can slow the progression of age-related macular degeneration.

This approval allows Kemin, owner of FloraGLO Lutein brand, to immediately begin marketing the product in Brazil: “Now Brazilian customers will be offered easy-to-use, convenient formulations that combine the two complementary ingredients, lutein and zeaxanthin” Kemin told NutritionInsight

The zeaxanthin in ZeaONE comes from a patented line of marigolds exclusively licensed to Kemin, and naturally contains high levels of the carotenoid zeaxanthin (3R, 3’R zeaxanthin) found in the red and orange fruits and vegetables in our diet. 

ZeaONE is commercially available under DSM’s brand OPTISHARP Natural.

Related Articles

Nutrition & Health News

Energetic growth: Energy boosters add pep to the nutritional space’s step

11 Dec 2017 --- Busy schedules can cause consumers to go through an “energy crisis” – prompting their desire to reach for products that might offer some support to their energy levels. Energy boosters are certainly showing signs of growth in all regions tracked by Innova Market Insights. A CAGR in supplement launches of +208.8 percent in South America from 2012 to 2016 is particularly noteworthy, while Europe is top of the pile worldwide with 28.8 percent of its supplement launches having an energy claim in 2016 and its CAGR amounting to a strong +86.7 percent.

Nutrition & Health News

Soy, cruciferous vegetables linked to fewer breast cancer treatment side effects

11 Dec 2017 --- Consuming soy foods and cruciferous vegetables – such as cabbages, kale, collard greens, bok choy, Brussels sprouts and broccoli – may be associated with a reduction in common side effects of breast cancer treatment in breast cancer survivors, according to a team of scientists led by Georgetown Lombardi Comprehensive Cancer Center. Understanding the role of life style factors with regard to the side effects is important because diet can serve as a modifiable target for possibly reducing symptoms among breast cancer survivors.

Business News

Consuming sugary drinks during pregnancy may increase asthma risk in mid-childhood

08 Dec 2017 --- Children between the ages of 7 and 9 may be at greater risk for developing asthma if they consumed high amounts of fructose in early childhood or their mothers drank a lot of sugar-sweetened beverages while pregnant, according to new research published online in the Annals of the American Thoracic Society.

Business News

New Biopolis probiotic mix helps reduce topical steroid use by atopic dermatitis patients

07 Dec 2017 --- Biopolis, majority owned by agricultural processor and food ingredient provider Archer Daniels Midland Company (ADM), has introduced a new probiotic mix designed to reduce the need for topical steroid use by Atopic Dermatitis (AD) patients. The clinical research recently published in JAMA Dermatology, an international peer-reviewed general medical journal, shows the benefits of consuming a mix of probiotics in reducing the need for topical steroids by AD patients.

Business News

High PUFA levels in children linked to reduced allergy risk

07 Dec 2017 --- High levels of omega 3 and omega 6 polyunsaturated fatty acids in children’s blood are associated with a reduced risk of asthma or rhinitis at the age of 16 years, according to new research from Karolinska Institutet in Sweden. The study is published in The Journal of Allergy and Clinical Immunology.

More Articles
URL : http://www.nutritioninsight.com:80/news/kemin-receives-anvisa-approval-for-sale-of-zeaone.html